Growth Metrics

HeartSciences (HSCS) Change in Account Payables (2021 - 2026)

HeartSciences filings provide 6 years of Change in Account Payables readings, the most recent being $93337.0 for Q1 2026.

  • On a quarterly basis, Change in Account Payables fell 27.21% to $93337.0 in Q1 2026 year-over-year; TTM through Jan 2026 was $5651.0, a 156.51% increase, with the full-year FY2025 number at -$129522.0, up 29.29% from a year prior.
  • Change in Account Payables hit $93337.0 in Q1 2026 for HeartSciences, up from $34165.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $633457.0 in Q4 2023 to a low of -$673221.0 in Q1 2024.
  • Median Change in Account Payables over the past 5 years was -$28194.0 (2022), compared with a mean of $5037.3.
  • Biggest five-year swings in Change in Account Payables: surged 970.47% in 2023 and later crashed 374.31% in 2024.
  • HeartSciences' Change in Account Payables stood at $339522.0 in 2022, then soared by 86.57% to $633457.0 in 2023, then tumbled by 118.89% to -$119658.0 in 2024, then soared by 128.55% to $34165.0 in 2025, then skyrocketed by 173.19% to $93337.0 in 2026.
  • The last three reported values for Change in Account Payables were $93337.0 (Q1 2026), $34165.0 (Q4 2025), and -$35436.0 (Q3 2025) per Business Quant data.